However, not all disorders have viable gene therapies yet—currently, no gene therapies are available for APRT deficiency, Lysinuric Protein Intolerance, or Fructose-1,6-bisphosphatase deficiency. The gene discussed is FBP1; the disease is adenine phosphoribosyltransferase deficiency.